# Low Dose Calcium to Prevent Preeclampsia

Study · id `cardio:ct-nct02338687` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02338687](<https://clinicaltrials.gov/study/NCT02338687>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02338687

Browse, organ or system: Blood vessels  
Browse, condition area: High blood pressure  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1040 participants.

## Technical summary

Registry record NCT02338687. Randomized; no masking; primary purpose prevention. Start 2014-10 (registry gives no type); primary completion 2018-10 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose prevention
- Phase: Phase 4
- Enrolled: 1040 participants (enrolled count; ClinicalTrials.gov record NCT02338687, source copy `cardio:ctgov-nct02338687-2023-10-12`, retrieved 2026-10-26)
- Start date: 2014-10 (registry gives no type) (ClinicalTrials.gov record NCT02338687, source copy `cardio:ctgov-nct02338687-2023-10-12`, retrieved 2026-10-26)
- Primary completion: 2018-10 (actual) (ClinicalTrials.gov record NCT02338687, source copy `cardio:ctgov-nct02338687-2023-10-12`, retrieved 2026-10-26)
- Completion: 2018-10 (actual) (ClinicalTrials.gov record NCT02338687, source copy `cardio:ctgov-nct02338687-2023-10-12`, retrieved 2026-10-26)
- Countries: Brazil (ClinicalTrials.gov record NCT02338687, source copy `cardio:ctgov-nct02338687-2023-10-12`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02338687-2023-10-12`, retrieved 2026-10-26)

## The registry's words

- Brief title: Low Dose Calcium to Prevent Preeclampsia
- Acronym: AMCAL
- Condition: Pre-Eclampsia
- Condition: Hypertension, Pregnancy-Induced
- Condition: Dietary Calcium Deficiency
- Intervention (Dietary supplement): calcium
- Intervention (Behavioral): Educational sessions
- Lead sponsor: Federal University of São Paulo
- Lead sponsor class: OTHER
- Collaborator: PPSUS (Programa Pesquisa para o SUS: gestão compartilhada em saúde)
- Collaborator class: UNKNOWN
- Collaborator: FAPEAM (Fundação de Amparo a Pesquisa do Estado do Amazonas)
- Collaborator class: UNKNOWN
- Collaborator: Universidade Federal do Amazonas
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Hypertension (high blood pressure) (`core:hypertension`)
- Registry lists this organization as the lead sponsor: Federal University of São Paulo (`cardio:org-federal-university-of-sao-paulo`)

## Provenance

Content hash: ecdfbdc373c9c51be0072baf14a0667063197e5a67cb665d178aeb1ee80ceefd
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
